CardioMEMS guided heart failure management in cardio-oncology patients: a tertiary care cancer center experience.

ABSTRACT:

Aims

Cancer patients and survivors are at increased risk of developing heart failure (HF) and heart failure hospitalization (HFH). Yet, the utilization of wireless pulmonary artery pressure sensing devices (PAPSD), like CardioMEMS, in this group is limited.

Objectives

We aimed to explore the utilization of CardioMEMS in managing HF among oncology patients.

Methods

We conducted a single-center retrospective study reviewing consecutive patients implanted with the CardioMEMS device between November 11, 2015, and February 21, 2023. We analyzed the device's impact on pulmonary artery pressures and HFH using statistical methods including Cox regression models and correlation studies between NT-proBNP levels and hemodynamic parameters.

Results

The study included 28 pa

SUBMITTER: Ali A 

PROVIDER: S-EPMC12273344 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature